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Mediawatch: Richard F. Harris
looks at the news reports
describing the world’s first
transgenic monkey.
There is a rhythm to many science
reports. First, the dramatic headline.
Next, the pithy lead paragraph,
which often promises more than
the story delivers. And then the
knockout quote — someone of
stature validating the story’s
premise. 
A funny thing happened with the
stories regarding ANDi, the world’s
first genetically modified primate.
We got the dramatic headlines, such
as: “How a Glowing Monkey Will
Help Cure Disease,” in The
Independent (London). We got the
pithy lead: “Heeeere’s ANDi, the
world’s first genetically engineered
monkey,” in New York’s Newsday.
But in most reports, the knockout
quote came from an obviously
biased source: the very scientists
who did the work. 
“We could just as easily
introduce, for example, an
Alzheimer’s gene to accelerate the
development of a vaccine for that
disease,” Gerald Schatten at the
Oregon Regional Primate Research
Center says near the top of the
report in USA Today and numerous
other publications. 
“I think we’re at an extraordinary
moment in the history of humans,”
reads the first quote in the Associated
Press article on the subject. Schatten
is again the speaker. 
And the first quote in the
Washington Post? “There are fantastic
discoveries now being made from
studies of human diseases in mice.
We’re optimistic that genetically
modified primates can translate some
of those discoveries in mice safely
and swiftly to people.” The source,
again, is Gerald P. Schatten. 
One of the few papers to quote
someone else first was the Pittsburgh
Post-Gazette. “I think it’s actually
quite a big deal,” said Dr. Ronald
Herberman, director of the
University of Pittsburgh Cancer
Institute. Alas, a few paragraphs later
we learn that Dr. Herberman is a
friend of Dr. Schatten’s, and hopes to
develop a collaboration with him. So
much for the independent validation. 
Read into the best stories on
the discovery, and the reason for
these self-congratulatory quotes
becomes clear: A lot of other
scientists don’t think the
accomplishment is a big deal. 
The Los Angeles Times, for
example, quoted University of
Southern California ethicist
Alexander Capron declaring that the
monkey is “hardly more of a
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harbinger of human genetic
engineering than modified mice, pigs
and other animals. In some ways, it’s
less advanced if the marker gene
isn’t functioning.” 
A few journalists interviewed
Rudolf Jaenisch of the Whitehead
Institute at MIT. Jaenisch told a
colleague at my network, National
Public Radio, the problem is
there’s no way to predict where
genes will end up when they are
introduced using retroviruses. “The
prospect of using this approach for
modeling human diseases unless
this is truly solved, not so good. So I
think the practical value for
medicine... is not revolutionizing.” 
The Washington Post noted that
many disease genes are simply too
big to fit inside a retrovirus. “The
whole transgenic field has moved
away from retroviruses because the
packaging size is very limited,”
David Ayares, vice president for
research at PPL Therapeutics in
Blacksburg, Va., told the Post. 
Nor was is it clear how an animal
model for, say Alzheimer’s disease,
could actually hasten development
of new therapies, if it first required
breeding colonies of monkeys with
susceptibility genes, waiting until
potential symptoms could appear,
and then conducting case-control
studies of various potential
therapeutics. 
But despite the many voices of
scientific skepticism, journalists
aren’t bold enough to ignore the
announcement or declare it a mere
publicity stunt. After all, the research
was supported by the National
Institutes of Health and published
in Science — so there must be folks
in the scientific establishment who
find the work worthy. 
And there’s no question about
the appeal of such a story. First is
the ‘Wow!’ factor of choosing a
fluorescent gene for the transfer
experiment. Even though ANDi
didn’t glow in the dark (or, to the
chagrin of his creators, even under
ultraviolet light), viewers of ABC’s
Good Morning America got to see
pictures of glowing mice during a
discussion of the monkey
experiment. Host Diane Sawyer
joked with reporter Michael Guillen
about adding that gene to human
beings: “It would be very useful to
mothers wanting to know exactly
what time their teen-agers come
home.” Guillen replied, “Oh yeah!
They can see them in the dark.” 
But ANDi was no joke in Britain,
where antivivisectionists are a much
bigger presence. 
Wendy Higgins, campaigns
director of the British Union for
the Abolition of Vivisection, told
The Times: “What will happen in
the future is that scientists will
either add or knock out genes in
primates to see what happens to
them. The end result is terrible
suffering. It’s bad enough using
rodents, but for scientists to play
God with primate genes is morally
abhorrent.” 
“Experimentation on primates is
particularly problematic because
they are closer to us, because we
know they are much more likely to
suffer in similar ways to us,” Sue
Mayer, of GeneWatch UK told
The Guardian. “We should think
extremely deeply before turning the
clock back and increasing the
number of experiments we sanction
on primates.” 
ANDi draws our collective
attention not because he represents a
great accomplishment, but because
the whole episode touches very close
to home. 
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Headline concern: The story of ANDi, the
first transgenic monkey created by US
researchers, as reported in London’s
The Guardian, reflects some of the concerns
raised in the British media about the
implications of such a development.
